Mostrando 7 resultados de: 7
Publisher
Annals of Hepatology(2)
Canadian Journal of Gastroenterology and Hepatology(1)
Clinical Gastroenterology and Hepatology(1)
Hepatitis Monthly(1)
Journal of Clinical Gastroenterology(1)
Área temáticas
Enfermedades(7)
Problemas sociales y servicios a grupos(4)
Producción(2)
Farmacología y terapéutica(1)
Medicina forense; incidencia de enfermedades(1)
Origen
scopus(7)
Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network
ArticleAbstract: Introduction and objectives: Most epidemiological data on hepatocellular carcinoma (HCC) originate fPalabras claves:Hispanics, Liver cirrhosis, NAFLDAutores:Anugwom C., Arrese M., Baca E.L., Balderramo D., Debes J.D., Enrique Carrera, Farah M., Ferrer J.D., Mattos A.Z., Possebon J.P.P., Prieto J.E.Fuentes:scopusAbnormal Liver Tests during Hospitalization Pbkp_redict Mortality in Patients with COVID-19: A Multicenter Study from South America
ArticleAbstract: Background. The role of liver function tests (LFT) as prognostic factors in patients admitted with CPalabras claves:Autores:Balderramo D., Bolomo A., Bombassaro I.Z., Carlino Y., Castillo L.T., Chiesa T., Debes J.D., Diaz-Ferrer J., Enrique Carrera, Jaysoom Abarca, Johana Acuña, Karina Díaz, Manero E., Mattos A.Z., Mulqui V., Plácido-Damián Z., Prieto J.E., Wiltgen D.Fuentes:scopusEarly Age Hepatocellular Carcinoma Associated With Hepatitis B Infection in South America
OtherAbstract:Palabras claves:Autores:Avendaño K., Balderramo D., Ballerga E.G., Barreyro F.J., Cairo F., Carrilho F.J., Chan A.J., Davalos M.B., Debes J.D., Enrique Carrera, Ferrer J.D., Gonçalves P.T., Hernández N., Hirsch B.S., Idrovo V., Kikuchi L., Mattos A.Z., Paredes S., Prieto J.E., Roberts L.R., Tapias M., Yang J.D.Fuentes:scopusHepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
ArticleAbstract: Background & Aims: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deatPalabras claves:demographics, hepatocellular carcinoma, RISK FACTORS, SOUTH AMERICAAutores:Avendaño K., Balderramo D., Barreyro F.J., Cairo F., Carrilho F.J., Chan A.J., Davalos M.B., Debes J.D., Diaz-Ferrer J., Enrique Carrera, Garcia J.A., Gonçalves P.T., Gonzalez-Ballerga E., Hernández N., Hirsch B.S., Idrovo V., Kikuchi L., Mattos A.Z., Paredes S., Prieto J.E., Roberts L.R., Tapias M., Yang J.D.Fuentes:scopusHepatocellular carcinoma, a unique tumor with a lack of biomarkers
OtherAbstract: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. InterPalabras claves:Biomarkers, Blood, HCCAutores:Boonstra A., Debes J.D., Enrique Carrera, Mattos A.Z., Prieto J.E.Fuentes:scopusPIB: A score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings
ArticleAbstract:Palabras claves:HCC, hepatocellular carcinoma, SCORE, SorafenibAutores:Balderramo D., Barreyro F.J., Carrilho F.J., Debes J.D., Diaz-Ferrer J., Diehl F., Enrique Carrera, Ferreiro M.R., Gonzalez-Ballerga E., Leathers J.S., Mattos A.Z., Prieto J.E., Singh D.Fuentes:scopusSorafenib for Treatment of Hepatocellular Carcinoma: A Survival Analysis from the South American Liver Research Network
ArticleAbstract: Goals:We aim to describe the efficacy, safety profile, and variables associated with survival in patPalabras claves:hepatocellular carcinoma, Sorafenib, SOUTH AMERICA, SurvivalAutores:Balderramo D., Barreyro F.J., Carrilho F.J., Debes J.D., Diaz-Ferrer J., Diehl F., Enrique Carrera, Ferreiro M.R., Gonzalez-Ballerga E., Leathers J.S., Mattos A.Z., Prieto J.E., Singh D.Fuentes:scopus